GPC4 and central nervous system cancer: The IPA analysis further unveiled enrichment of pathways associated with brain development, synaptogenesis, and axonal guidance, providing potential explanations for the impact of GPC4 in glioma and glioblastoma, which originate from neuronal and non-neuronal stem cells.